// App-Quantinova.ai

1707 : The Association of Serum Biomarkers and Metabolic Syndrome with Subclinical Atherosclerosis in Systemic Lupus Erythematosus: A Controlled Analysis in Patients with No Clinical Disease Activity

Researchers

Presenter

  • Semra Ertan-Demir

Principal Investigators

  • Ahmet Yasar Cizgici

  • Gaye Erten

  • Bahar Artim-Esen

  • Yasemin Sahinkaya

  • Ozlem Pehlivan

  • Nilufer Alpay-Kanitez

  • Kadri Atay

  • Huseyin Oflaz

  • Gunnur Deniz

  • Murat Inanc

Medical Centers

  • Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

  • Department of Immunology, Istanbul University, Institute of Experimental Medicine DETAE, Istanbul, Turkey

  • Cardiology Department, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

  • Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Metabolic syndrome

  • Coronary Artery Disease

Biomarkers

  • E-selectin

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Tumor necrosis factor

Drug/Treatment

  • Interleukin

  • sICAM-1

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved